×

Neurodiversity

The Neurodiversity category celebrates and explores the varied ways human brains can function, encompassing conditions such as autism, ADHD and other cognitive profiles. It highlights lived experience, research, support strategies and societal perspectives, while advocating for understanding, inclusion and respect. With thoughtful, informed content, this category aims to broaden appreciation of neurological differences and promote wellbeing across diverse communities.

TMS study could be helpful for epilepsy prognosis

Transcranial magnetic stimulation (TMS) measured cortical inhibition provides insight into interindividual differences in progressive myoclonic epilepsy. In patients with progressive myoclonic epilepsy type 1 (EPM1),...
TMS study could be helpful for epilepsy prognosis

Stranded dolphins show signs of Alzheimer’s

Stranded dolphins show signs of Alzheimer’s: The brains of three different species of stranded dolphins show classic markers of Alzheimer’s disease, according to a new...
Stranded dolphins show signs of Alzheimer’s

In Ocean – an autistic perspective

In Ocean - an autistic perspective: I am a sea creature forced to live upon land. Although the earth has many marvels, I still long...
In Ocean – an autistic perspective

Potential new biomarker for ADHD and ASD

A new potential biomarker for Attention Deficit Hyperactivity Disorder (ADHD) and Autism has been found. “It’s often said that ‘the eyes tell it all’, but...
Potential new biomarker for ADHD and ASD

ASD medication trial targeting gut bacteria

A new trial will test whether a medication that targets gut bacteria can also improve irritability in teenagers with autism spectrum disorder (ASD). The Tapestry...
ASD medication trial targeting gut bacteria

Learning from babies

What can we learn from babies and how the brain has an amazing ability to ‘get to work’ on autism spectrum: Toddlers climb on everything...
Learning from babies

Comment on Alzheimer’s drug lecanemab

Alzheimer's Society and Professor Sir John Hardy respond to results for Alzheimer's drug lecanemab: A paper published today in The New England Journal of Medicine...
Comment on Alzheimer’s drug lecanemab

Underweight babies at risk

Research shows all underweight babies may be at higher risk of childhood developmental complications – not just those with extremely low birthweights Babies with mild...
Underweight babies at risk